1 min read
Add as a preferred source on GoogleHims & Hers Health Shares Rise as HHS Plans Temporary Peptide Compounding
The proposed interim policy would let compounding pharmacies make six peptides, including a popular tissue-repair peptide.
Hims & Hers Health (HIMS) shares rose Wednesday, Oct. 28, after the U.S. Department of Health and Human Services (HHS) announced plans to temporarily allow compounding pharmacies to make six peptides.
The proposed interim policy would include a popular tissue-repair peptide.
Enna Lee
ReporterEnna Lee reports on investing and digital-asset markets for TokenPost. Send corrections or tips to info@tokenpost.com.